Table 1 Description of Group Data Used for Model Development, Biomarker Assessment, and validation of NDD profiles.
Cohort name | Label | Model development (n) | Validation cohort descriptors | |||
|---|---|---|---|---|---|---|
Training | ROC-AUC | Size (n) | Age | Female | ||
Control group | CG | 58 | 61 | 186 | 62 ± 9.5 | 46% |
Alzheimers disease dementia | AD | 27 | 29 | 37 | 73 ± 7.8 | 27% |
Lewy body dementia | LBD | 18 | 18 | 19 | 70 ± 6.2 | 11% |
REM sleep behavior disorder | iRBD/pSYN | 15 | 19 | 33 | 66 ± 10.0 | 27% |
Parkinson’s disease | PD | --- | 17 | 29 | 65 ± 9.6 | 24% |
Mild cognitive impairment | MCI | --- | 40 | 86 | 70 ± 9.9 | 45% |
